Market Access/ News/ News FDA clears Marinus’ Ztalmy as first drug for rare epilepsy Phil Taylor epilepsy, ganaxolone, Marinus Pharma, rare disease, regulatory approval, Ztalmy 0 Comment People with CDKL5 deficiency disorder (CDD) now have their first FDA-approved treatment, after the US regulator gave the Share X FDA clears Marinus’ Ztalmy as first drug for rare epilepsy https://pharmaphorum.com/news/fda-clears-marinus-ztalmy-as-first-drug-for-rare-epilepsy/